depression with semaglutide People pre-existing or anxiety were less likely to have mental health worsening while taking a GLP-1 medication, observational Swedish data suggested. https://www.medpagetoday.com/psychiatry/generalpsychiatry/120515 Association between GLP-1 receptor agonist

Last Published 07.01.2026 Effective Date: 07.01.2026 This policy addresses the use of interleukin-5 (IL-5) antagonists, including Cinqair (reslizumab), Fasenra (benralizumab), and Nucala (mepolizumab)

[1] [2] While highly effective for weight loss, gastrointestinal side effectsincluding stomach pain, nausea, and abdominal discomfortare among the most commonly reported adverse reactions

Kimur I, Tanizaki Y, Sato S, Saito K, Takahashi K

It is crucial to follow the dosage recommendations provided by a healthcare professional and monitor for any adverse effects

Saxenda, a GLP-1 receptor agonist, commonly causes nausea and stomach upset, whilst ibuprofen, an NSAID, may irritate the gastric lining